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Abstract 
Inflammatory bowel disease (IBD) is characterized by chronic and relapsing intestinal 
inflammation of unknown etiology, but immune activation by the commensal microbiota 
probably plays a major role. The two major categories of IBD are ulcerative colitis and 
Crohn’s disease. One fifth of the cases present in childhood and Sweden has a high and rising 
incidence of pediatric IBD. The aim of this thesis was to study the composition of the small 
and large intestinal microbiota and signs of activation on lymphocyte subsets in the blood 
circulation in children at the début of IBD, before initiation of treatment. Further, the 
requirements of commensal Gram-positive bacteria to initiate production of IL-12, a cytokine 
stimulating Th1 reactions in innate immune cells, was studied using blood obtained from 
healthy donors.  
Blood, faecal and duodenal samples were obtained from children referred to a pediatric 
gastroenterology centre due to suspected IBD. Samples of the microbiota were cultivated 
quantitatively for aerobic and anaerobic bacteria. After establishment of diagnosis, the 
composition of the microbiota and lymphocyte subsets were compared between children with 
ulcerative colitis, Crohn’s disease, symptomatic children found not to have IBD (diseased 
controls) and healthy controls. The microbiota mainly in children with ulcerative colitis was 
shown to be altered, with decreased counts of anaerobic Gram-positive bacteria such as 
bifidobacteria and clostridia. Whereas bifidobacterial counts normalized with treatment, 
clostridial populations remained low. Both children with ulcerative colitis and Crohn’s 
disease had an increased fraction of Gram-negative bacteria in the stools, compared with 
controls. Blood cell subsets were analysed by flow cytometry for activation and memory 
markers. Children with ulcerative colitis displayed strong activation of circulating T cells, 
especially manifested as increased expression of β1-integins. Children with Crohn’s disease 
had few memory B-cells, suggesting immunological immaturity.  
Our studies further revealed that Gram-positive bacteria are major stimuli for IL-12 
production in monocytes as long as they remain intact, but that fragments of Gram-positive 
bacteria inhibit IL-12 production in blood cells. This may be a physiological feedback circuit, 
since such fragments may signal that further activation of the phagocyte via the IL-12/IFN-γ 
loop is unnecessary. IL-12 production in response to intact Gram-positive bacteria required 
phagocytosis, activation of TLR2- and Nod2-receptors, demonstrated by chemical blocking, 
anti-human TLR antibodies, and binding of synthetic or natural ligands. Further, IL-12 
production induced by intact Gram-positive bacteria required signalling via PIP3, NF-κB and 
JNK. These pathways differed from those inducing IL-12 production in response to LPS in 
interferon-γ primed monocytes. Thus, Gram-positive bacteria have unique and important 
immunomodulating properties that may influence IBD development. 
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